3 completed, 1 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow ridinilazole: new trials by email Literature Review of ridinilazole trials Research Report on ridinilazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects Ridinilazole, Vancomycin - Clostridioides Difficile Infection | Phase 3 | Terminated | Summit Therapeutics | 2 | 2021-05-19 | 2023-08-21 |
| Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection Ridinilazole, Vancomycin - Clostridioides Difficile Infection | Phase 3 | Completed | Summit Therapeutics | 759 | 2019-01-28 | 2026-10-09 |
| A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) Ridinilazole, Fidaxomicin - Clostridium Difficile Infection | Phase 2 | Completed | Summit Therapeutics | 27 | 2014-12-01 | 2017-10-12 |
| A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD) SMT19969, Vancomycin - Clostridium Difficile Infection | Phase 2 | Completed | Summit Therapeutics | 100 | 2014-04-01 | 2016-10-20 |
Clostridium Infections (4) · Diarrhea (1) · Infections (1)
United States (4) · Canada (2) · Argentina (1) · Australia (1) · Brazil (1) · Bulgaria (1) · Czechia (1) · Greece (1) · Hungary (1) · New Zealand (1) · Poland (1) · Romania (1) · Russia (1) · South Korea (1) · Spain (1)
Lori Styles, MD (2) · Richard Vickers, PhD (1)